Evidence map›Paper›PMID 39135116›Full record

ArticleHealth research policy and systems2024

Development and pilot implementation of a novel protocol to assess capacity and readiness of health systems to adopt HPV detection-based cervical cancer screening in Europe.

Keitly Mensah, Isabel Mosquera, Anna Tisler, Anneli Uusküla, João Firmino-Machado, Nuno Lunet, Florian Nicula, Diana Tăut, Adriana Baban, Partha Basu and 1 more

Erratum issued Registry-linked trialAbstract read
In one paragraph

Article in Health research policy and systems, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT07678047 (Leveraging Project ECHO for Improved Cervical Cancer Screening in Ethiopia), which is not on this map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07678047 naenrolling by invitationnot on this mapstarted 2026, after this paper: background citation

Leveraging Project ECHO for Improved Cervical Cancer Screening in Ethiopia: An Implementation Study of Integrated HPV Selfsampling in HIV Care Centers

TypeinterventionalSponsorAlbert Einstein College of MedicineRan2026 to 2029Enrolled60ConditionsCervical Carcinoma, Human Papilloma Virus (HPV)ArmsTICHILALECH ECHO
3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Keitly MensahEarly Detection, Prevention, and Infections Branch, International Agency for Research On Cancer, 25 Avenue Tony Garnier, 69366, Lyon Cedex 07, France.
Isabel MosqueraEarly Detection, Prevention, and Infections Branch, International Agency for Research On Cancer, 25 Avenue Tony Garnier, 69366, Lyon Cedex 07, France. MosqueraI@iarc.who.int.
Anna TislerUniversity of Tartu, Tartu, Estonia.
Anneli UuskülaUniversity of Tartu, Tartu, Estonia.
João Firmino-MachadoInstituto de Saúde Pública da Universidade Do Porto, Porto, Portugal.
Nuno LunetInstituto de Saúde Pública da Universidade Do Porto, Porto, Portugal.
Florian NiculaInstitute of Oncology Cluj-Napoca, Cluj-Napoca, Romania.
Diana TăutUniversitatea Babes Bolyai, Cluj-Napoca, Romania.
Adriana BabanUniversitatea Babes Bolyai, Cluj-Napoca, Romania.
Partha BasuEarly Detection, Prevention, and Infections Branch, International Agency for Research On Cancer, 25 Avenue Tony Garnier, 69366, Lyon Cedex 07, France.
CBIG-SCREEN Consortium

Funding

Horizon 2020 Framework Programme Grant Agreement No 964049World Health Organization 001
6 · The paper itself

Abstract

backgroundCervical cancer remains a significant public health concern in Europe. Effective introduction and scaling up of human papillomavirus (HPV) detection-based cervical cancer screening (CCS) requires a systematic assessment of health systems capacity. However, there is no validated capacity assessment methodology for CCS programmes, especially in European contexts. Addressing this gap, our study introduces an innovative and adaptable protocol for evaluating the capacity of CCS programmes across varying European health system settings.

methodsOur research team developed a three-step capacity assessment framework, incorporating a health policy review checklist, a facility visit survey, and key informants' interview guide followed by a strengths, weaknesses, opportunities and threats (SWOT) analysis. Piloting this comprehensive approach, we explored the CCS capacity in three countries: Estonia, Portugal and Romania. These countries were selected due to their contrasting healthcare structures and resources, providing a diverse overview of the European context.

resultsConducted over a period of 9 months, the capacity assessment covered multiple resources, 27 screening centres, 16 colposcopy and treatment centres and 15 key informant interviews. Our analysis highlighted both shared and country-specific challenges. A key common issue was ensuring high compliance to follow-up and management of screen-positive women. We identified considerable heterogeneity in resources and organization across the three countries, underscoring the need for tailored, rather than one-size-fits-all, solutions.

conclusionsOur study's novelty lies in the successful development of this capacity assessment methodology implementable within a relatively short time frame, proving its feasibility for use in various contexts and countries. The resulting set of materials, adaptable to different cancer types, is a ready-to-use toolkit to improve cancer screening processes and outcomes. This research marks a significant stride towards comprehensive capacity assessment for CCS programmes in Europe. Future directions include deploying these tools in other countries and cancer types, thereby contributing to the global fight against cancer.

Indexed as

Early Detection of CancerMass ScreeningPapillomavirus InfectionsUterine Cervical NeoplasmsCapacity BuildingColposcopyDelivery of Health CareEuropeFemaleHealth PolicyHumansPapillomaviridaePilot ProjectsPortugalRomaniaCapacity assessmentCervical cancerContextual analysisEstoniaEuropeFacility visitHPV-based screeningImplementationInterviewPortugalRomaniaScreeningVulnerable women

Identifiers

PMID39135116
PMCPMC11318142

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.